These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23499937)

  • 1. ATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint-like inclusion body formation, and selective degeneration of dopaminergic neurons.
    Matsui H; Sato F; Sato S; Koike M; Taruno Y; Saiki S; Funayama M; Ito H; Taniguchi Y; Uemura N; Toyoda A; Sakaki Y; Takeda S; Uchiyama Y; Hattori N; Takahashi R
    FEBS Lett; 2013 May; 587(9):1316-25. PubMed ID: 23499937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.
    Yang X; Xu Y
    Biomed Res Int; 2014; 2014():371256. PubMed ID: 25197640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.
    Schultheis PJ; Fleming SM; Clippinger AK; Lewis J; Tsunemi T; Giasson B; Dickson DW; Mazzulli JR; Bardgett ME; Haik KL; Ekhator O; Chava AK; Howard J; Gannon M; Hoffman E; Chen Y; Prasad V; Linn SC; Tamargo RJ; Westbroek W; Sidransky E; Krainc D; Shull GE
    Hum Mol Genet; 2013 May; 22(10):2067-82. PubMed ID: 23393156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.
    Demirsoy S; Martin S; Motamedi S; van Veen S; Holemans T; Van den Haute C; Jordanova A; Baekelandt V; Vangheluwe P; Agostinis P
    Hum Mol Genet; 2017 May; 26(9):1656-1669. PubMed ID: 28334751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of human Atp13a2Isoform-1 protein protects cells against manganese and starvation-induced toxicity.
    Ugolino J; Dziki KM; Kim A; Wu JJ; Vogel BE; Monteiro MJ
    PLoS One; 2019; 14(8):e0220849. PubMed ID: 31393918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function.
    Anand N; Holcom A; Broussalian M; Schmidt M; Chinta SJ; Lithgow GJ; Andersen JK; Chamoli M
    Neurobiol Dis; 2020 Jun; 139():104786. PubMed ID: 32032734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigral ATP13A2 depletion induces Parkinson's disease-related neurodegeneration in a pilot study in non-human primates.
    Sikora J; Dovero S; Kinet R; Arotcarena ML; Bohic S; Bezard E; Fernagut PO; Dehay B
    NPJ Parkinsons Dis; 2024 Aug; 10(1):141. PubMed ID: 39090150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities.
    Erb ML; Sipple K; Levine N; Chen X; Moore DJ
    NPJ Parkinsons Dis; 2024 Jul; 10(1):133. PubMed ID: 39030200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kufor Rakeb syndrome without gaze palsy and pyramidal signs due to novel ATP13A2 mutations.
    Satolli S; Di Fonzo A; Zanobio M; Pezzullo G; De Micco R
    Neurol Sci; 2023 Oct; 44(10):3723-3725. PubMed ID: 37306797
    [No Abstract]   [Full Text] [Related]  

  • 10. ATP13A2 (PARK9) and basal ganglia function.
    Croucher KM; Fleming SM
    Front Neurol; 2023; 14():1252400. PubMed ID: 38249738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kufor-Rakeb syndrome-associated psychosis: a novel loss-of-function ATP13A2 variant and response to antipsychotic therapy.
    Colijn MA; Vrijsen S; Au PYB; Abou El Asrar R; Houdou M; Van den Haute C; Sarna J; Montgomery G; Vangheluwe P
    Neurogenetics; 2024 Jul; ():. PubMed ID: 39023817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile Parkinson Disease.
    Anwar A; Saleem S; Akhtar A; Ashraf S; Ahmed MF
    Cureus; 2019 Aug; 11(8):e5409. PubMed ID: 31632863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic assays in yeast and zebrafish reveal drugs that rescue
    Heins-Marroquin U; Jung PP; Cordero-Maldonado ML; Crawford AD; Linster CL
    Brain Commun; 2019; 1(1):fcz019. PubMed ID: 32954262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM structures and transport mechanism of human P5B type ATPase ATP13A2.
    Chen X; Zhou M; Zhang S; Yin J; Zhang P; Xuan X; Wang P; Liu Z; Zhou B; Yang M
    Cell Discov; 2021 Nov; 7(1):106. PubMed ID: 34728622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction to: ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.
    Hum Mol Genet; 2024 May; 33(10):930. PubMed ID: 38512067
    [No Abstract]   [Full Text] [Related]  

  • 16. Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.
    Sato S; Li Y; Hattori N
    J Neural Transm (Vienna); 2017 Nov; 124(11):1395-1400. PubMed ID: 28894968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
    Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
    Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
    Park JS; Blair NF; Sue CM
    Mov Disord; 2015 May; 30(6):770-9. PubMed ID: 25900096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells.
    Bae EJ; Lee C; Lee HJ; Kim S; Lee SJ
    Exp Neurobiol; 2014 Dec; 23(4):365-71. PubMed ID: 25548536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy.
    Lopes da Fonseca T; Outeiro TF
    Exp Neurobiol; 2014 Dec; 23(4):314-23. PubMed ID: 25548531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.